Is the pandemic treaty a step towards World Government?
By Dr Deborah Ancell | TCW Defending Freedom | May 25, 2022
Dear Prime Minister,
It’s the Davos World Economic Forum (WEF) season and conspiracies about World Government abound. I have a new one for you.
You might recall my letter concerning the opaqueness of the first international tax, the United Nations Carbon Offsetting Reduction Scheme for International Aviation (CORSIA)
CORSIA offsets aircraft carbon dioxide emissions and it’s hidden in the environmental provisions of the UN’s International Civil Aviation Organisation. CORSIA empowered the UN to raise taxes – something which appears to have escaped notice in signatory sovereign nations.
My concerns were that firstly, CO2 is not a pollutant and secondly, CORSIA is a Trojan horse for similar UN taxes on other industries such as shipping and information technology.
Taxation is the tool of national governments. When nations surrender tax powers to an international body, they undermine their sovereignty. CORSIA enables independent, non-political, commercial funding of UN development projects in developing nations and reduces their reliance on UN member-government funding.
CORSIA also provides developing world reparations, since it offsets (unevidenced) claims that underdevelopment results from historical emissions incurred during developed world industrialisation. As the first international tax, it’s an example of UN overreach which undermines national sovereignty.
Now another UN arm – the World Health Organisation – might also be attempting overreach. WHO is proposing a new ‘pandemic treaty’ to encourage more information-sharing in the event of another global health crisis.
The treaty would apparently give WHO ‘unprecedented, undemocratic jurisdiction over its 194 member nations, including the UK’. There would be almost unlimited authority to ‘order mandatory vaccines, digital health IDs, lockdowns, isolation, testing regimes, no-jab-no-job rules, or anything else it decided as policy, irrespective of dissenting voices’.
The treaty will not be voted on until the World Health Assembly in 2023. If the UK agreed to this, health sovereignty could also be undermined.
Combine these two sovereignty concessions and you have the beginnings of an independently-funded and legislating World Government. This prospect was promoted by now-deceased luminaries as diverse as discredited socialist millionaire Maurice Strong and capitalist banker David Rockefeller.
Strong, a promoter of CO2 as a cause of environmental harm, profoundly believed that the UN had the potential to be the World Government. Any such World Government would undermine democracies.
Similarly, Rockefeller founded and led the Trilateral Commission with its aim of a ‘New World Order’ to control population and resources. He is reported as stating that ‘the supranational sovereignty of an intellectual elite and world bankers is surely preferable to the national auto-determination (democracy) practised in past centuries.’ Scary!
Conspiracy theorists believe that today’s WEF, with its agenda to counter natural and anthropogenic climate change and its call for a Great (economic) Reset has a similar, shadowy agenda to these precursor pursuits.
As conspiracy theories go, this one is far-fetched – but can you assure me I’m wrong? Do you think that World Government is on the agenda at Davos today?
Yours sincerely,
Deborah Ancell
What it means that Hillary Clinton did it
By David Zukerman | American Thinker | May 22, 2022
The Wall Street Journal ran a scathing editorial on May 20, called “Hillary Clinton Did It“.
This editorial began: “The Russia-Trump collusion narrative of 2016 was a dirty trick for the ages — and now we know it came from the top — candidate Hillary Rodham Clinton.” The editorial quickly explained: “That was the testimony Friday by 2016 Clinton campaign manager Robby Mook in federal court [in Washington, D.C.], and while this news is hardly a surprise, it’s still bracing to find her fingertips on the political weapon.” (Also not surprisingly, The May 20 print edition of The New York Times did not include a story on Mook’s testimony.)
Mook’s testimony was heard at the trial of attorney Michael Sussman, charged with lying to the FBI in calling to their attention a story that Donald J. Trump, by means of connections with Russia’s Alfa Bank, was colluding with Russian President Vladimir Putin.
The lie at issue was not the false claim about a Trump-Alfa connection, but the charge that Sussman brought this matter to the FBI as a good citizen, and not as a representative of the Clinton campaign.
As the Journal editorial noted: “Prosecutors say [Sussman] was working for the Clinton campaign.” The editorial pointed out, “Mr. Mook said Mrs. Clinton was asked about the plan [to call attention to the Trump-Alfa ties] and approved it. A story on the Trump-Alfa Bank allegations thus appeared in Slate, a left-leaning online publication.”
After that, the Journal explained how the Clinton campaign used the self-generated news of the investigation and the initial Slate article that came of it, both of which they had planted, as the basis for making tweet after tweet to the press about the Slate report to churn up mass coverage about it in the press and convince the public that the investigation was about something serious.
The concluding paragraphs of the editorial are worth quoting in full:
In short, the Clinton campaign created the Trump-Alfa allegation, fed it to a credulous press that failed to confirm the allegations but ran with them anyway, then promoted the story as if it was legitimate news. The campaign also delivered the claims to the FBI, giving journalists another excuse to portray the accusations as serious and perhaps true.
Most of the press will ignore this news, but the Russia-Trump narrative that Mrs. Clinton sanctioned did enormous harm to the country. It disgraced the FBI, humiliated the press, and sent the country on a three-year investigation to nowhere. Vladimir Putin never came close to doing as much disinformation damage.
The harm done to the United States by the perfidy of the Clintonistas cannot be overemphasized. That “three-year investigation to nowhere” represented the Clinton-Obama attempted takeover of the government. (Call it the COAT campaign.) With congressional Republicans unwilling to prevent the COAT campaign, the Trump administration was blocked from putting U.S.-Russia relations on a rational, mutually beneficial footing, to the point that, under the present Senate leadership, the specter of war with Russia is no longer an unthinkable thought. The COAT campaign succeeded in keeping the Ukraine pot boiling, with the water first heated by Obama’s stirring up of anti-Russian feelings in Ukraine, leading to the Maidan revolution that ousted the legitimately elected president of Ukraine, Viktor Yanukovych.
Biden Says Record-High Gas Prices Part of ‘Incredible Transition’ US Going Through
Samizdat | May 24, 2022
Following the beginning of Russia’s special military operation in Ukraine on 24 February, the US and several of its allies cut off all imports of Russian oil and gas, which added greatly to soaring gas prices for Americans.
President Joe Biden has argued that the current record-high gas prices in his country are part of America’s major transition from fossil fuels.
“Here’s the situation. And when it comes to gas prices, we’re going through an incredible transition that is taking place that, God willing, when it’s over, we’ll be stronger and the world will be stronger and less reliant on fossil fuels when this is over,” he said during a joint press conference with Japan’s Prime Minister Fumio Kishida on Monday.
POTUS then insisted that his administration’s actions helped “keep it [the gas prices] from getting worse — and it’s bad”.
“The price of gas at the pump is something that I told you — you heard me say before — it would be a matter of great discussion at my kitchen table when I was a kid growing up,” Biden said before admitting, “It’s affecting a lot of families.”
House Republican Steve Scalise was quick to respond by telling reporters that Biden is “saying the quiet part out loud now.” In an apparent nod to the Biden administration, Scalise added that “they’re causing you pain at the pump because it’s all part of their radical agenda.”
He spoke as the national average for a gallon of regular gas in the US stood at $4.56 as of Monday, which is more than $0.40 higher than it was just a month ago.
In some US states such as California, the average price for a gallon of regular gas has meanwhile already reached $6.06.
While Biden previously tried to cast the price increases as the fault of Russian President Vladimir Putin, labelling high gas prices “Putin’s price hike”, the recent polls show that Americans aren’t buying it.
A survey conducted by conservative pollster Rasmussen found that beliefs about the importance of rising gas prices were essentially unchanged since November 2021, but that a majority (51%) of American voters surveyed held POTUS responsible for higher fuel prices. Another 26% blamed oil companies for the price hike, while just 15% blamed Putin.
The NHS just edited their Monkeypox page… to make it scarier
OffGuardian | May 24, 2022
Afew days ago the UK’s National Health Service (NHS) edited their Monkeypox page to alter the narrative in a few key ways.
Firstly, they removed a paragraph from the “How do you get Monkeypox?” section.
Up until a few days ago, according to archived links, the Monkeypox page said this, regarding person-to-person tranmission [emphasis added]:
It’s very uncommon to get monkeypox from a person with the infection because it does not spread easily between people.
… this has now been totally removed.
Secondly, they’ve removed this paragraph, which was present up until at least November of 2021 (and maybe much more recently, there are no archives between November and May) [emphasis added]:
[Monkeypox] is usually a mild illness that will get better on its own without treatment. Some people can develop more serious symptoms, so patients with monkeypox in the UK are cared for in specialist hospitals.
The new “treatment” paragraph reads [again, emphasis added]…
Treatment for monkeypox aims to relieve symptoms. The illness is usually mild and most people recover in 2 to 4 weeks […] You may need to stay in a specialist hospital, so your symptoms can be treated and to prevent the infection spreading to other people.
So, they remove that it will “get better on its own”, and again reinforce the idea of spreading the disease despite this being described as “very uncommon” as recently as last week.
They even add a line about self-isolating, which was never mentioned before:
as monkeypox can spread if there is close contact, you will need to be isolated if you’re diagnosed with it.
Finally, they now include a warning you can get Monkeypox by eating undercooked meat, which will doubtless feed into the anti-meat narrative too (oh, wait, it already is).
To sum up, history is being re-written a little here.
Before, monkeypox “did not spread easily between people”. Now it does.
Before, monkeypox would “get better on its own without treatment”. Now it won’t.
It’s early days to say that Monkeypox is going to be the “new Covid”, and maybe this rollout will stall and be forgotten in a couple of weeks, but there’s no doubt they are taking some tips from the Covid playbook so far.
Concerns of Fraud in Pfizer Vaccine Trial as Participant’s Hospitalisation with Heart Inflammation is Swept Under Carpet
By Will Jones | The Daily Sceptic | May 23, 2022
You may have heard the disturbing story of Maddie de Garay, who in July 2020, aged 12, participated in Pfizer’s Covid vaccine trial of adolescents aged 12-15. Within 24 hours of receiving the second dose in early January 2021, Maddie experienced “zapping pain up and down her spine with severe abdominal pain… her toes and fingers turned white and were ice cold”. She now can barely see, suffers from tinnitus, mobility issues, vomiting, blood in her urine, numbness in her body and has at least 10-20 seizures a day. Yet her injury was recorded in the vaccine trial data as “abdominal pain” and it was asserted without investigation to be not related to the vaccine.
Another case, similarly disturbing, has now emerged of an adverse reaction during a Pfizer trial that was not recorded in the trial data, raising concerns about the integrity of the trial data and the possibility of fraud.
Augusto Roux is a 35-year old lawyer from Buenos Aires, Argentina who volunteered for Pfizer’s Covid vaccine phase 3 trial. He did so to protect his mother, who has emphysema.
On the way home after his second dose on September 9th 2020, he began feeling unwell, developed a high fever and felt very ill. He fainted on September 11th and went to the hospital on September 12th. The hospital ran tests, including a CAT scan of his chest, which showed an abnormal collection of fluid around the outside of the heart, indicating pericarditis (a form of heart inflammation).
On September 14th he was discharged, with the doctor writing in his discharge note that he had suffered an adverse reaction to the vaccine. Augusto was also told by hospital staff that there had been a considerable number of people from the clinical trial coming to the hospital – one nurse estimated staff had seen around 300 people – so his experience was not new to them. Around 3,000 trial participants had been enrolled before Augusto, so, if the nurse’s estimate is accurate, this would be a hospitalisation rate of 10%.
Following his adverse reaction, Augusto asked to see his trial clinical records, but those running the trial refused. Being a lawyer, Augusto went to law to get access to his records, which took over a year. Once he saw them, he could well imagine why someone might not want them to be released.
In hospital, Augusto had tested negative for Covid, and the doctor at the hospital had written that his condition was due to the vaccine. However, when Augusto contacted the trial site on September 14th to notify the investigators he had been in hospital, they wrote down in his clinical trial record that he had been admitted for a “bilateral pneumonia” that had nothing to do with the “investigational product” – the vaccine – even though that was not what he told them or what the doctor who examined him had stated.
For obvious reasons, Augusto was keen to know whether he’d had the vaccine or not. However, the principal investigator for the trial, Fernando Polack (pictured below), had inaccurately claimed that he could only be unblinded if his life were in danger. Augusto appealed to ANMAT, the Argentinian equivalent of the FDA, and following a formal hearing on October 9th 2020 it forced the trial investigators to tell Augusto that he had, indeed, received the vaccine.
The clinical trial notes reveal that two days prior to this hearing, on October 7th, “at the request of the sponsor” (Pfizer), the adverse event code was updated from pneumonia to “COVID-19 disease”. This is despite Augusto testing negative at the time of his admission. (Conveniently for Pfizer, the COVID-19 ‘diagnosis’ would not be included in the trial vaccine efficacy calculations due to the negative test.)
Even more disturbing, on October 8th, Polack wrote in Augusto’s clinical trial records that he had had an attack of “severe anxiety” starting on September 23rd (not caused by the vaccine, naturally). Polack added that Augusto suspected a conspiracy between the two hospitals, described his anxiety as “constitutional”, and noted that it was ongoing, evidenced by his pursuing his appeal to ANMAT. On October 11th, Polack had this mental health diagnosis added to his actual medical records.
Dr. David Healy, who has interviewed Augusto and seen the medical records in question, comments that “there is nothing in any record that indicates that Dr. Polack or any other doctor attempted on September 23rd to establish whether Augusto had a mental disorder”. He adds:
Augusto points to the notes of October 8th and 11th as evidence that this idea was invented just around the time the ANMAT hearing was about to happen. He states that it is in breach of Argentinian law for Dr. Polack to have diagnosed someone with a medical condition that the person does not have – and to have entered it into his medical record.
Note that Polack is a paediatrician so lacks the qualification to make mental health diagnoses, especially without any formal assessment.
Polack is a key player in the Pfizer Covid vaccine trials. He was the lead author on the December 2020 NEJM paper on the safety and efficacy of the vaccine. Israeli academic Josh Guetzkow notes that he is also one of the directors of i-trials, the site management organisation “paid handsomely by Pfizer to run the trial in Argentina (the largest site of the trial by far)”. Guetzkow adds:
If he raised an alarm about the vaccine safety, his company would have lost a ton of money and would be an unlikely choice by any company to run any trials in the future. So to say that he had an interest in achieving a positive trial outcome would be quite an understatement. There may be other conflicts we’re not aware of.
The evidence of malpractice and possible fraud in the Pfizer Covid vaccine trials is certainly stacking up now. But very few people are aware of it as it is mostly only being reported in alternative media. When will mainstream outlets start following up properly on this potentially massive story?
FDA Dumps More Pfizer Documents: Why Were So Many Adverse Events Reported as ‘Unrelated’ to Vaccine?
By Michael Nevradakis, Ph.D. | The Defender | May 17, 2022
The latest release of Pfizer-BioNTech COVID-19 vaccine documents raises questions about how frequently adverse events experienced by clinical trial participants were reported as “unrelated” to the vaccine.
The 80,000-page document cache released May 2 by the U.S. Food and Drug Administration (FDA) includes an extensive set of Case Report Forms (CRFs) from Pfizer trials conducted at various locations in the U.S.
The documents also include the “third interim report” from BioNTech’s trials conducted in Germany (accompanied by a synopsis of this report and a database of adverse events from this particular set of trials).
The FDA released the documents, which pertain to the Emergency Use Authorization (EUA) of the vaccine, as part of a court-ordered disclosure schedule stemming from an expedited Freedom of Information Act (FOIA) request filed in August 2021.
Public Health and Medical Professionals for Transparency, a group of doctors and public health professionals, submitted the FOIA request.
Adverse events during Pfizer vaccine trials in the U.S. usually reported as ‘unrelated’ to vaccination
Pfizer conducted a series of vaccine trials at various locations in the U.S., including the New York University Langone Health Center, Rochester Clinical Research and Rochester General Hospital (Rochester, New York) and the J. Lewis Research, Inc. Foothill Family Clinic (Salt Lake City, Utah).
The Pfizer documents released this month by the FDA included a series of CRFs for patients who suffered some type of adverse event during their participation in the COVID-19 vaccine trials.
As the documents reveal, despite the occurrence of a wide range of symptoms, including serious cardiovascular events, almost none were identified as being “related” to the vaccine.
Such serious yet “unrelated” adverse events included:
- Acute asthma exacerbation
- Aortic aneurysm (listed as a pre-existing condition)
- Appendicitis (requiring hospitalization)
- Atrial defibrillation
- Cardiac arrest and acute respiratory failure, requiring hospitalization, sustained by a patient who then was “lost” (could not be located for continued participation in the trial)
- Chest pain (requiring hospitalization, later listed as cardiac ischemia)
- Coronary artery occlusion (listed as both serious and life-threatening)
- Injuries sustained from a fall
- Intermittent non-cardiac chest pain (requiring hospitalization)
- Left breast cancer (listed as a pre-existing occult malignancy)
- Neuritis (peripheral nerve Injury), listed as “unrelated” to the vaccine but related to the blood draw during vaccination
- Pulmonary embolism and bilateral deep venous thrombosis
- Respiratory failure (requiring hospitalization)
- Right ureteropelvic junction obstruction (requiring hospitalization, listed as congenital)
- Small bowel obstruction, listed as “unplanned,” and a panic attack
Of the CRFs found in the documents released this month, only one adverse event is clearly specified as being related to the vaccination: a participant who suffered from psoriatic arthritis, with no prior history of the condition.
In addition, several CRFs indicated exposure during pregnancy (see here and here), or during a partner’s pregnancy (see here and here). However, the documents provided do not appear to have provided any follow-ups regarding any outcomes or potential adverse events for the participants, their partners or their newborn babies once born.
In some instances, while the CRFs claimed the adverse events suffered by patients were not related to the vaccine, their cause was unspecified, simply indicated as “other,” while in another case, a participant’s “unplanned” small bowel obstruction and panic attacks were listed as being unrelated to the vaccination despite no relevant medical history pertaining to the SAEs (severe adverse events) in question.
Did Pfizer hide critical information from regulators?
It is difficult to draw concrete conclusions about any specific case from the data provided by CRFs and vaccine trial summaries.
However, what raises eyebrows is the very large number of adverse events — often serious and often requiring the hospitalization of the patients involved — that were determined to be “unrelated” to the administration of the COVID vaccine.
Previously released Pfizer documents also included discrepancies in the recording of adverse events.
According to investigative journalist Sonia Elijah, these discrepancies include:
- Trial participants were entered into the “healthy population” but were, in actuality, far from healthy.
- SAE numbers were left blank.
- Barcodes were missing from samples collected from trial participants.
- The second vaccine dose was administered outside the three-week protocol window.
- New health problems were dismissed as “unrelated” to the vaccination.
- A remarkable number of patients with an observation period of exactly the same duration — 30 minutes, with very little variety in observation times and raising questions as to whether patients were adequately observed or were put at risk.
- Oddities pertaining to the start and end dates of SAEs – for instance, a “healthy” diabetic suffered a “serious” heart attack on October 27, 2020, but the “end” date for this SAE is listed as the very next day, even though the patient was diagnosed with pneumonia that same day.
- Impossible dating: in the aforementioned example of the patient who sustained a heart attack and pneumonia, the individual in question later died, but the date of death is indicated as the day before the patient was recorded as having gone to a “COVID ill” visit.
- Unblinded teams, who were aware of which patients received the actual vaccine or a placebo, were responsible for reviewing adverse event reports, potentially leading to pressure to downplay COVID-related events in the vaccinated, or to indicate that adverse events were related to the vaccine.
- Other adverse events were indicated as “not serious” despite extensive hospital stays, of up to at least 26 days in the case of one patient who suffered a fall which was classified as “not serious,” yet facial lacerations sustained as a result of the fall were attributed to hypotension (low blood pressure).
Many of these practices seem to appear in the trial-related documents released this month.
Medical and scientific experts who spoke to The Defender expressed similar concerns about what this month’s tranche of documents reveals, and addressed cases of “disappearing” adverse events.
Brian Hooker, chief scientific officer for Children’s Health Defense, remarked:
“I’m most concerned about ‘disappearing’ patients. One cannot conduct a valid trial and simply omit the results that they don’t like!
“With the stories about Maddie de Garay and Augusto Roux surfacing, I have to wonder how many other participants were dropped in order to hide vaccine adverse events/effects.
“If you look at the data in VAERS [Vaccine Adverse Event Reporting System], COVID-19 vaccines are the most dangerous ever introduced into the population.”
Dr. Madhava Setty, a board-certified anesthesiologist and senior science editor for The Defender, said:
“The ‘unrelated’ label the investigators use to divert attention from AEs [adverse events] is a powerful point that stands on its own. We haven’t pushed back on this enough.
“Equivalently, we can say that the meager and short-lived benefit of these shots is also ‘unrelated’ using their ‘standards.’ On what grounds can they say that their product is preventing infection (which it isn’t anymore), or death (marginally)?
“They cannot have it both ways. They cannot claim a benefit through short-term outcomes while denying that side effects of any kind are related to their product.
“That’s the whole point of doing a trial. You cannot prove causation, only statistically significant correlation.”
Setty provided further context for his remarks in an April 2022 article for The Defender and in a March 2022 presentation, in which he discussed the number of these adverse events and how Pfizer swept them away (timestamp 24:00).
In Setty‘s view:
“There’s a high likelihood of malfeasance going on. [Pfizer whistleblower] Brook Jackson says the PIs [principal investigators] were unblinded. If true, it would make it very easy for the investigators to bump up the AEs in the placebo group while ignoring some of the AEs in the vaccine group.
“Pfizer claims that 0.5% of placebo recipients suffered a serious adverse event compared to 0.6% in the vaccine group. This is how these events were obscured.”
The extant body of evidence indicates Pfizer “is hiding critical information from regulators,” Setty said:
“The clincher is in the memorandum to the VRBPAC [Vaccines and Related Biological Products Advisory Committee] (Table 2, efficacy populations), where they show us that five times more people in the vaccine group were pulled out of the trial than the placebo within seven days of their second shot for ‘important protocol deviations.’
“In a trial that big the chances that could have happened coincidentally is infinitesimally small (less than 1 in 100,000).
“Moreover, months later, the same thing happened in the pediatric trial (Table 12). This time, six times more children were pulled from the trial after their second dose.
“There are, of course, procedural differences when administering a placebo versus the mRNA vaccine, but why didn’t it happen after the first dose as well?
“Mathematically, that is about as close as you can get to eliminating any ‘shadow of doubt.’ With a formal allegation by a trial coordinator that states the same thing [referring to whistleblower Brook Jackson], we can be assured Pfizer is hiding critical information from regulators.”
BioNTech trials in Germany claim few adverse events ‘related’ to vaccine
The BioNTech trial in Germany tested various dosages of two COVID-19 vaccine formulas, labeled BNT162b1 and BNT162b2 — the latter granted EUA by the FDA.
The latest cache of Pfizer documents suggests a pattern, similar to the one in the U.S. trials, of not reporting adverse events as related to the vaccine.
According to the third interim report, dated March 20, 2021, among trial participants who were administered the BNT162b2 candidate vaccine granted EUA in the U.S.:
- 87% of younger participants reported solicited local reactions, and 88% reported solicited systemic reactions, with 10% reporting solicited systemic reactions of Grade 3 or higher.
- 87% of younger participants experienced “mild” solicited local reactions, and 35% experienced “moderate” solicited local reactions.
- 88% of younger participants experienced “mild” solicited systemic reactions, and 38% experienced “moderate” solicited systemic reactions. As stated in the report:
“The most frequently reported solicited systemic reactions of any severity were fatigue (n=40, 67%), followed by headache (n=32, 53%), malaise (n=24, 40%), and myalgia (n=23, 38%). The remaining symptom terms were less frequent.
“For nausea, headache, fatigue, myalgia, chills, arthralgia and malaise each symptom was assessed as severe in <10% of participants.”
- 43% of younger participants reported a total of 51 unsolicited TEAEs (treatment-emergent adverse events, referring to conditions not present prior to treatment or that worsened in intensity after treatment) within 28 days of the first or second dose, nine of which were deemed to be “related” to the vaccination. One participant in this category sustained a TEAE assessed as Grade 3 or higher, but “which was assessed as not related by the investigator.”
- TEAEs among younger participants included hypoaesthesia, lymphadenopathy, heart palpitations, external ear inflammation, blepharitis, toothache, non-cardiac chest pain, cestode infection, oral herpes, tonsillitis, neck pain, insomnia, anosmia and dysmenorrhea.
- No unsolicited treatment-emergent serious adverse events (TESAEs) or deaths were reported among younger participants, but one discontinued participation due to moderate nasopharyngitis.
- One younger participant “discontinued due to a moderate AE (nasopharyngitis).”
- 86% of older participants reported solicited local reactions, with 6% reporting solicited local reactions of Grade 3 or higher, 78% reporting “mild” solicited local reactions and 36% reporting “moderate” solicited local reactions.
- 72% of older participants reported solicited systemic reactions, with 11% of these participants sustaining solicited systemic reactions of Grade 3 or higher, 69% sustaining “mild” solicited reactions and 36% sustaining “moderate” solicited reactions.
- 33% of older participants reported a total of 20 unsolicited TEAEs, four of which were determined to be “related” to the vaccination. Among older participants, 8% reported a TESAE of Grade 3 or higher, with “one event assessed as related by the investigator.”
- One older participant was reported to have sustained a “not related TESAE” (an ankle fracture).
- TESAEs among older participants included back pain, chest pain, facial injury, increased lipase, increased amylase, muscle spasms, musculoskeletal pain, tendon pain, orthostatic intolerance, renal colic, seborrhoeic dermatitis and “painful respiration.”
Among trial participants who received the BNT162b1 candidate vaccine (not granted EUA):
- 86% of “younger participants” reported solicited (expected) localized reactions (remaining in one part of the body), with 18% reporting Grade 3 or higher solicited local reactions, 86% of younger participants reporting “mild” solicited local reactions and 54% reporting “moderate” solicited local reactions.
- 92% of younger participants reported solicited systemic reactions (spreading to other parts of the body), with 44% reporting Grade 3 or higher solicited systemic reactions, 90% reporting “mild” solicited systemic reactions and 74% experiencing “moderate” solicited systemic reactions.
The report states:
“The most frequently reported solicited systemic reactions of any severity were fatigue (n=68, 81%), headache (n=66, 79%), myalgia (n=51, 61%), malaise (n=50, 60%), and chills (n=47, 56%). The remaining symptom terms were less frequent.
“For nausea, vomiting, diarrhea, myalgia, arthralgia and fever each symptom was assessed as severe in ≤10% of participants.”
- 45% of younger participants reported a total of 83 unsolicited (unexpected) TEAEs within 28 days of receiving the first or second dose.
A total of 51 of these unsolicited TEAEs were reported as “related” to the vaccination, while 2% of participants sustained Grade 3 or higher TEAEs (four in total), “of which three events were assessed as related by the investigator.”
No unsolicited TESAEs or deaths were reported in this category.
- According to the report, among younger participants, TEAEs included:
“‘General disorders and administration site conditions’ reported by 9 participants (11%),” including influenza-like illness and injection site hematoma.
“‘Nervous system disorders’ reported by 10 participants (12%),” including presyncope, hyperaesthesia, paraesthesia, and headache.
“‘Respiratory, thoracic and mediastinal disorders’ reported by 9 participants (11%),” including cough and oropharyngeal pain.”
Other symptoms included back pain, musculoskeletal chest pain, cervicobrachial syndrome, taste disorder, sleep disorder, depression, hallucination, dysmenorrhoea, pruritus and pityriasis rosea, while one participant required the excision (removal) of a papilloma.
- One younger participant discontinued participation in the trial, “due to a moderate AE (malaise),” while another participant discontinued participation “due to dose-limiting toxicity.”
- 83% of “older participants” reported solicited local reactions, but none were reported as Grade 3 or higher, while 83% of solicited local reactions were “mild” and 42% were “moderate.”
- 92% of older participants reported solicited systemic reactions, with 28% of participants experiencing Grade 3 or higher solicited systemic reactions, 89% experiencing “mild” solicited systemic reactions, and 61% experiencing “moderate” solicited systemic reactions.
According to the report:
“The most frequently reported solicited systemic reactions of any severity were headache (n=29, 81%), fatigue (n=27, 75%), myalgia (n=18, 50%), and malaise (n=18, 50%). The remaining symptom terms were less frequent.”
- 36% of participants reported a total of 24 unsolicited TEAEs within 28 days of the first or second dose, nine of which were assessed as “related” to the vaccination.
Of the participants in this category, 11% reported TEAEs of Grade 3 or higher (four events in total), with one of these events assessed as “related” to the vaccination.
- TEAEs reported by older participants included oropharyngeal pain, nasopharyngitis, bladder dysfunction, sleep disorder, musculoskeletal pain and musculoskeletal chest pain, pollakiuria, migraine, syncope and alopecia.
- One older participant receiving the BNT162b1 candidate sustained a TESAE (syncope), and there were no deaths in this category.
Of note, none of the participants for either vaccine candidate were pregnant, which raises questions about recommending and administering the vaccine to pregnant women despite the absence of any clinical trial data.
As the documents show, a wide range of adverse effects were reported, including cardiovascular and nervous system conditions, most of which were determined to be unrelated to the vaccination itself.
Michael Nevradakis, Ph.D., is an independent journalist and researcher based in Athens, Greece.
© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
Monkeypox Fears May Rescue Endangered Corporations
By Whitney Webb |
Unlimited Hangout| May 20, 2022
In recent days, concern over a global outbreak of monkeypox, a mild disease related to smallpox and chickenpox, has been hyped in the media and health ministries around the world, even prompting an emergency meeting at the World Health Organization (WHO). For some, fears have centered around monkeypox being the potential “next pandemic” after Covid-19. For others, the fear is that monkeypox will be used as the latest excuse to further advance draconian biosecurity policies and global power grabs.
Regardless of how the monkeypox situation plays out, two companies are already cashing in. As concern over monkeypox has risen, so too have the shares of Emergent Biosolutions and SIGA Technologies. Both companies essentially have monopolies in the US market, and other markets as well, on smallpox vaccines and treatments. Their main smallpox-focused products are, conveniently, also used to protect against or treat monkeypox as well. As a result, the shares of Emergent Biosolutions climbed 12% on Thursday, while those of SIGA soared 17.1%.
For these companies, the monkeypox fears are a godsend, specifically for SIGA, which produces a smallpox treatment, known by its brand name TPOXX. It is SIGA’s only product. While some outlets have noted that the rise in the valuation of SIGA Technologies has coincided with recent concerns about monkeypox, essentially no attention has been given to the fact that the company is apparently the only piece of a powerful billionaire’s empire that isn’t currently crumbling.
That billionaire, “corporate raider” Ron Perelman, has deep and controversial ties to the Clinton family and the Democratic party as well as troubling ties to Jeffery Epstein. Aside from his controlling stake in SIGA, Perelman has recently made headlines for rapidly liquidating many of his assets in a desperate bid for cash.
Similarly, Emergent Biosolutions has also been in hot water. The company, which has troubling ties to the 2001 Anthrax attacks, came under fire just under two weeks ago for engaging in a “cover up” over quality control issues relating to their production of Covid-19 vaccines. A Congressional investigation found that quality control concerns at an Emergent-run facility led to more than 400 million doses of Covid-19 vaccines being discarded. The Emergent factory in question had been shut down by the FDA in April 2021. They were allowed to reopen last August before the government terminated the contract. Given that the majority of the company’s business is tied to US government contracts, the loss of this contract, and the accompanying poor publicity, the news that its smallpox vaccine may soon be of international interest is likely seen as a godsend by the company.
Notably, this is the second time in a year that both companies have benefitted from pandemic or bioterror fears propagated by the media. Last November, speculation rose that a re-emergence of the eradicated virus that causes smallpox would soon take place. This first began with Bill Gates’ comments on the prospects of smallpox bioterrorism during a November 4th, 2021 interview and was followed by the November 16th announcement of a CDC/FBI investigation into 15 suspicious vials labeled “smallpox” at a Merck facility in Philadelphia. Now, roughly six months later, the same fears are again paying off for the same two companies.
A Killer Enterprise
Emergent Biosolutions was previously known as BioPort. The company was founded by Fuad el-Hibri, a Lebanese businessman, who leveraged his contacts with powerful US former military officials and politicians, to take control of a flailing Michigan factory. It was the only factory authorized to produce an anthrax vaccine.
The anthrax vaccine was known to have major problems even before BioPort had acquired it, and is believed by many investigators to be one of the main causes of “Gulf War” syndrome. The vaccine itself, originally developed at Fort Detrick, had little to no safety track record at the time it was administered to US troops in the First Gulf War – a problem that was never remedied. However, its chronic safety issues and its clumsy, multi-dose regimen would later prompt BioPort/Emergent Biosolutions to spend years developing a new formulation of its anthrax vaccine.
The creation of BioPort coincided with the Clinton administration’s efforts to mandate the anthrax vaccine for all members of the US Armed Forces. With control over the only source of anthrax vaccine, BioPort was poised to make a killing.
Once the company acquired the Michigan facility, it took large amounts of US government funds, ostensibly to make improvements at the site. However, the company declined to use the funds to make the necessary repairs, instead spending that money on its executives’ offices, as opposed to the vaccine factory, and millions more on bonuses for “senior management.” Pentagon auditors would later find that still millions more had gone “missing” and BioPort’s staff were unaware of the cost of producing a single dose of the vaccine. Despite the clear mismanagement and corruption, BioPort demanded to be bailed out by the Pentagon, and they were. Meanwhile, the Michigan facility lost its license after a government inspection found numerous safety issues.
However, by August 2001, BioPort stood to lose the Pentagon contracts – its only source of income. The Pentagon began preparing a report, due to be released in September 2001, that would detail a plan for letting BioPort go. Thanks to the September 11, 2001 attack on the Pentagon, that report was never released. Shortly thereafter, the 2001 anthrax attacks began.
Just months before, BioPort had contracted Battelle Memorial Institute to help rescue its flailing vaccine program. The deal gave Battelle “immediate exposure to the vaccine” and it was used in connection with the Pentagon-funded, gain-of-function anthrax program that involved both Ken Alibek and William C. Patrick III, two bioweapons experts with deep ties to the CIA. That program was housed at Battelle’s West Jefferson facility in Ohio. That facility is believed by many investigators to be the source of the anthrax used in the 2001 attacks.
The ensuing panic from the anthrax attacks led the Department of Health and Human Services (HHS) to intervene. They gave BioPort its license back in January 2002 despite persisting safety concerns at its vaccine production facility in Michigan. BioPort was not content to merely see its past contracts with the Pentagon restored, however, as it began lobbying heavily for new contracts for anthrax vaccines intended for American civilians, postal workers and others. They would get them, largely thanks to HHS’ then-counter-terrorism adviser and soon to be HHS’ newest Assistant Secretary — Jerome Hauer. Hauer would later join the board of BioPort, after it reformed as Emergent Biosolutions, in 2004.
Such examples of cronyism are more common than not when it comes to Emergent Biosolutions. Indeed, the company has frequently relied on individuals who spend their careers passing through the “revolving door” between the pharmaceutical industry and government, particularly those who also moonlight as bioterror alarmists. One of the main individuals critical to the company’s success over the years has been Robert Kadlec. Kadlec served as the top bioterror advisor to the Pentagon in the weeks leading up to the 2001 anthrax attacks. Months prior, he had participated in the June 2001 simulation Dark Winter, which “predicted” major aspects of the subsequent anthrax attacks. Kadlec subsequently crafted much of the legislation that would create the country’s subsequent bioterror/pandemic response policy, including BARDA and the Strategic National Stockpile.
Soon after leaving government, Robert Kadlec helped found a new company in 2012 called “East West Protection,” which develops and delivers “integrated all-hazards preparedness and response systems for communities and sovereign nations.” The company also “advises communities and countries on issues related to the threat of weapons of mass destruction and natural pandemics.”
Kadlec formed the company with W. Craig Vanderwagen, the first HHS Assistant Secretary for Preparedness and Response (a position Kadlec had helped write into law and would later hold himself). The other co-founder of East West Protection was Fuad El-Hibri, the founder of BioPort/Emergent Biosolutions, who had just stepped down as Emergent’s CEO earlier that year.
Kadlec then became a consultant. Kadlec’s consultancy firm, RPK Consulting, netted him $451,000 in 2014 alone, where he directly advised Emergent Biosolutions as well as other pharmaceutical companies like Bavarian Nordic. Kadlec was also a consultant to military and intelligence contractors, such as the DARPA-backed firm Invincea and NSA contractor Scitor, which was recently acquired by SAIC.
Kadlec would return to government as HHS ASPR under Trump, a position which he held at the time the Covid-19 crisis began. The year prior, in 2019, Kadlec had conducted a months-long simulation focused on a global pandemic originating in China called Crimson Contagion. Once the Covid-19 crisis began in earnest, he played a major role in securing Covid-19 vaccine contracts for Emergent Biosolutions, despite his conflicts of interest, some of which he had declined to disclose upon being appointed to serve as ASPR.
Emergent Biosolutions’ pattern of corrupt behavior, beginning with its anthrax vaccine, can be seen with its recent actions as it relates to its production of Covid-19 vaccines. Per the recent Congressional report, released just days before the recent spike in concern over monkeypox began, Emergent lab workers “intentionally sought to mislead government inspectors about issues” at its Baltimore-based plant and also repeatedly “rebuffed” efforts by AstraZeneca and Johnson & Johnson to inspect their facilities. “Despite major red flags at its vaccine manufacturing facility, Emergent’s executives swept these problems under the rug and continued to rake in taxpayer dollars,” House Oversight and Reform Committee Chairwoman Carolyn Maloney (D-NY) stated upon the report’s release. Yet such “major red flags” can be found throughout the company’s entire history, for those willing to take the time to look.
Just days after the Congressional report was released, Emergent Biosolutions announced that it would acquire the exclusive worldwide rights to the “first FDA-approved Smallpox Oral Antiviral for all ages” from the company Chimerix. The drug, called TEMBEXA, is only for the treatment of smallpox, which the company refers to as “a high priority public health threat.” The press release on the company’s acquisition of TEMBEXA states that multi-million US government contracts for the product are anticipated. The FDA formally approved the drug last June.
Emergent Biosolutions also has the rights to the smallpox vaccine known as ACAM2000, which can also be used to treat monkeypox. The vaccine, originally produced by Sanofi, was acquired by the company in 2017. As a result, the company has an essential monopoly over smallpox vaccines as ACAM2000 is “the only vaccine licensed by the FDA for active immunization against smallpox disease for people determined to be at high risk of smallpox infection.”
Given their track record, it’s worth asking why Emergent Biosolutions has been working in recent months to pivot much of its business into smallpox treatments. However, there is no speculation needed when observing that the current monkeypox fears and helping rescue the company, whose shares had fallen some 26% year to date before concern over the recent monkeypox outbreak began to grow.
Whatever comes of the monkeypox situation, Emergent Biosolutions’ decades-long track record is undeniably one of corruption and cronyism.
“BioArmor” for Ron Perelman’s Flailing Business Empire
SIGA Technologies, which likens its products to “Human BioArmor”, features a quote from Bill Gates at the top of its about page. The quote reads: “[…] the next epidemic could originate on the computer screen of a terrorist intent on using genetic engineering to create a synthetic version of the smallpox virus […]” The quote is from Bill Gates’ speech to the 2017 Munich Security Conference, where he used the threat specifically of smallpox to argue that “health security” and “international security” be merged. Notably, last March, the Munich Security Conference hosted a simulation of a global pandemic caused by a “genetically engineered monkeypox virus.”
SIGA is one example of a company that seeks to find its niche in the middle of “health security” and “international security.” It specifically provides “solutions for unmet needs in the health security market that comprises medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats, as well as emerging infectious diseases.” The majority of contracts for CBRN medical countermeasures in the US are funded by the Pentagon. While it promotes itself as a CBRN threat-focused company, SIGA is, for now, singularly focused on smallpox.
Indeed, SIGA Technologies is only currently profitable in the event of an actual outbreak of smallpox or a related disease, or when fear of a smallpox bioterror event is high. Specifically, concern over the latter has led to the company to win government contracts to produce TPOXX for the Strategic National Stockpile (SNS). This is because TPOXX is only used to treat active smallpox or monkeypox infection, not prevent it. This means that it is only useful if smallpox, monkeypox or a related disease is actively infecting people or if there is a high risk that one of these diseases will soon infect large groups of people. TPOXX was first approved in 2018 by the FDA and was approved by the European Medicine Agency (EMA) this past January. The FDA approved an intravenous version of TPOXX just this past Thursday. Overall, SIGA has received over $1 billion from the US government to develop TPOXX.
SIGA is currently partnered with HHS’ BARDA, the Department of Defense, the CDC and the NIH. Another partner is Lonza, a European pharmaceutical manufacturing firm that is partnered with both the World Economic Forum and Moderna. SIGA’s CEO, Phillip Gomez, is an alumni of PRTM Consulting, where he would have worked closely with Robert Kadlec, as the two men overlapped as directors of the firm and both worked advising government agencies on matters of public health and biodefense.
SIGA is also notable because it is possibly the only company in the business empire of corporate raider Ron Perelman that is not attached to growing mountains of debt. Perelman is one of the notorious corporate raiders from the 1980s who conducted corporate takeovers fueled by junk bonds, particularly those connected to Michael Milken’s Drexel Burnham Lambert. Perelman’s business tactics have long been informed by his volcanic temper and his ruthlessness, with former Salomon Brothers CEO John Gutfruend once remarking that “believing Mr. Perelman has no hostile intentions is like believing the tooth fairy exists.”
Perelman is also known for being a long-time patron of the Clinton family, even though, more recently he donated to Donald Trump’s political campaigns. Perelman apparently first became interested in courting influence with the Clintons after marrying Patricia Duff in 1994. Duff was deeply connected to the Democratic Party, having worked for Democratic pollster Pat Cadell, and she had also worked for the House panel that “investigated” the assassinations of John F. Kennedy and Martin Luther King Jr. Prior to marrying Perelman, she had been married to movie mogul Michael Medavoy and had “introduced Clinton to the Hollywood establishment,” according to the Washington Post.
As Perelman’s wife, Duff styled herself a leading Democratic fundraiser, with the 1995 fund-raising dinner being emblematic of that. Also, in 1995, Perelman attended a $1,000-a-plate dinner in New York for the Clintons, where Perelman sat across from the President, as well as a state dinner for Brazil’s president at the White House.
For Perelman, his generosity to the Clinton political machine resulted in an appointment by Clinton to the board of trustees of the Kennedy Center in 1995. Other, less public gestures from the Clintons were likely, as Perelman offered much more to the First Family than he appears to have received in return. Perhaps most notable of Perelman’s favors for Bill Clinton was his offering of jobs to scandal-ridden members of his administration, Webster Hubbell and Monica Lewinsky, in the wake of their respective controversies. However, after the job offers were publicly reported, both Hubbell and Lewinsky were let go, though the offers later caught the attention of independent counsel Ken Starr. Starr never subpoenaed or investigated Perelman or the offers he had made to Hubbell or Lewinsky.
The controversial hirings had been arranged between Perelman and Clinton advisor Vernon Jordan, who sat on the board of Revlon, a Perelman-controlled company, while his wife was on the board of another Perelman-owned firm. Jordan was known as Clinton’s “conduit to the high and mighty” and had taken Clinton to the 1991 Bilderberg conference. On the decision to hire Lewinsky following the scandal, a former business associate of Perelman’s told the Washington Post that “It’s like the Mafia, it’s all done in code,” adding that “I can assure you that Ronald made the decision to give Lewinsky the job. And I can assure you he wouldn’t want to know why Jordan was asking.”
In 1995, Perelman held a Clinton fundraiser at his mansion, with guests including singer Jimmy Buffett, Miami Vice actor Don Johnson, actor Michael Douglas’ then-wife Deandra and DNC co-chair Don Fowler. Other guests included A. Paul Prosperi, a corrupt Clinton crony, and the now infamous Jeffrey Epstein. Clinton himself attended the fundraiser. According to the Palm Beach Post, guests had donated at least $100,000 to the DNC to attend the dinner with the President. This was, of course, in the lead up to the 1996 election, and the DNC would later come under heavy scrutiny due to illegal fundraising. This fundraiser was not Epstein’s only interaction with Perelman – Perelman would later be listed as a frequent dinner guest of Epstein’s in the 2003 Vanity Fair profile penned by Vicky Ward and is listed in Epstein’s black book of contacts.
For most of the 2000s, Perelman has sat atop a massive, ever-growing fortune. Yet, since 2020, Perelman has “been unloading assets ‘A lot of them. Rapidly.’” It started with sales of valuable paintings at Sotheby’s and soon extended to Perelman’s investment company MacAndrews & Forbes, which disposed of its interest in two companies that same year, including $1 billion in shares in Scientific Games. According to MoneyWeek, Perelman’s net worth dropped from $19 billion in 2018 to $4.2 billion in late 2020, “prompting speculation that he’s running out of money.” Over the course of last year, Perelman has continued to “downsize”, looking to sell off his estate in the Hamptons for $115 million, another 57-acre estate worth $180 million and two townhouses in Manhattan’s Upper East Side for $60 million.
Other assets held by Perelman’s company MacAndrews & Forbes are also drowning in debt. One of the few assets of the company that isn’t currently haemorrhaging money or struggling with debt is its shares in SIGA Technologies. Perelman’s main company, MacAndrews & Forbes, has long been one of SIGA’s biggest investors and remains its largest shareholder, controlling 33% of all shares.
Since Perelman got involved with SIGA, accusations of corruption have plagued the company. For instance, in May 2011, SIGA was given a no-bid contract worth about $433 million to develop and produce 1.7 million doses of anti-viral drug for smallpox. At the time there was no evidence the smallpox drug in question was capable of treating the disease and there was alarm among some HHS staffers that SIGA’s return on investment from the contract was “outrageous.” The contract began to be investigated over concerns that the contract had been awarded to SIGA precisely because it was controlled by Perelman, who had donated heavily to Barack Obama. At the time, CNN noted the following about Perelman’s connections to the Obama White House:
“Ronald Perelman is controlling shareholder of Siga Technologies and a longtime Democratic Party activist and fundraiser. He’s also a large contributor to Republicans, but has been a particular friend of the Obama White House.
Also on Siga’s board of directors is Andy Stern, former president of the Service Employees International Union, who has had close relations with the Obama administration and who has supported President Barack Obama’s health care initiatives.”
As a result of these concerns and the potential conflict of interest, a congressional investigation began. Days after learning that this key government contract may be in jeopardy, SIGA executives sold off large amounts of company stock at an average price of $13.46 per share, netting its Chief Executive Officer and Chief Scientific Officer at the time millions of dollars. A month later, the company announced that its contract had been downsized and shares in the company fell to under $2 by that December.
Given past “pay-to-play” accusations around Perelman’s role in the firm during the Obama administration, when President Joe Biden served as Vice President, what are we to make of the recent media hype around monkeypox? Or concerns raised last year of a bioterrorism event involving smallpox?
Perhaps it’s more important to ask other questions – why has Perelman’s role in SIGA been largely obfuscated or totally ignored by recent reporting on the company? Similarly, why has Emergent Biosolutions’ horrific track record also been excluded from recent reports, including the major complaints from Congress made against the company less than two weeks ago? It seems the fear being generated around monkeypox is not only boosting shares for these two rotten companies, it’s helping the public forget their past sins.
Whitney Webb has been a professional writer, researcher and journalist since 2016. She has written for several websites and, from 2017 to 2020, was a staff writer and senior investigative reporter for Mint Press News. She currently writes for The Last American Vagabond.
The DHS’ latest appointment to the Disinformation Board adds to its credibility problem
Michael Chertoff himself has pushed false claims about disinformation and is a prime example of how boards such as this shouldn’t exist
By Didi Rankovic | Reclaim The Net | May 20, 2022
The US administration is getting further entangled in missteps, in an attempt to create a credible Disinformation Governance Board.
The latest addition to the outfit, former Department of Homeland Security Secretary Michael Chertoff – now nominated as the board’s adviser by the same agency – is unlikely to add to the credibility or clear up “confusion” about the board’s role – given that he, too, in the past peddled misinformation, reports say.
The infamous case of the Hunter Biden laptop is at the center of it all, as more officials who have pushed the now-debunked theory that the emails retrieved from the device were not authentic but a Russian conspiracy are getting appointed to the board.
This new government body is often referred to by critics as the “Ministry of Truth” – a reference to Orwell’s “1984” where the said ministry served a purpose opposite of “truth” – its job was to falsify historical events in order to advance government propaganda.
Chertoff – along with former CIA director Leon Panetta and several others who also in the past broadcast what turned out to be false claims that the publishing of the Biden emails was “a Russian operation” are now joining the board in advisory roles.
The necessity to do something to save face shortly after this body was launched comes because of the actions of its executive director, Nina Jankowicz, who also believes that the emails coming to light were the result of “a Russian influence operation.”
Chertoff himself said in the wake of the 2020 election – ahead of which the Biden laptop story was suppressed and censored by Big Tech and Big Media – that it was the Russians who got their hands on the emails and that those saying they were recovered from Hunter Biden’s abandoned computer were “preposterous.”
Nearly two years later, however, there has been no evidence to prove otherwise. The authenticity of emails messages has been forensically verified, and the repair shop owner, John Paul Mac Isaac, said that Hunter Biden left the laptop there in 2019 and never came back.
Isaac first gave a copy of the hard drive to the FBI later that year, and then to President Trump’s associates, who forwarded the documents to the New York Post.
Clinton ordered leak of bogus ‘Russiagate’ story to press, ex-aide tells court
Samizdat | May 20, 2022
Former Clinton campaign manager Robby Mook told a federal court in Washington, DC on Friday that, in 2016, Hillary Clinton approved leaking to the media a story claiming that the Trump Organization had been in contact with Russia’s Alfa Bank. The story originated with one of Clinton’s lawyers, and is false.
Mook, who ran Clinton’s unsuccessful campaign in 2016, told the court that campaign lawyer Marc Elias approached him claiming to have proof that servers connected with Russia’s Alfa Bank exchanged data with servers belonging to the Trump Organization. He said that he had been assured that the evidence had come from “people that had expertise in this sort of matter.”
Mook said that nobody on the campaign was “totally confident” in the information, and that he asked Clinton whether he should release it to the media. “She agreed,” he said, and the information was released.
Once the claims were published by Slate, an online news source, the Clinton campaign put out a statement describing the supposed Alfa Bank server exchange as “the most direct link yet between Donald Trump and Moscow.” Then-Clinton adviser and current National Security Advisor Jake Sullivan wrote the statement, saying that the Alfa Bank allegations raise “even more troubling questions in light of Russia’s masterminding of hacking efforts … to hurt Hillary Clinton’s campaign.”
However, the allegations were false. Special Counsel Robert Mueller’s report into “collusion” between the Trump campaign and Russia made no mention of the server allegations, and found no evidence of “collusion” or Russian “hacking efforts” to influence the 2016 election.
Furthermore, an FBI investigation into the allegations found that there was “nothing there,” the agency’s former general counsel, James Baker, testified in the same courtroom on Thursday. Both Mook and Baker were testifying in the trial of Michael Sussmann, who first brought the Alfa Bank allegations to the FBI.
Sussman is charged with making false statements to the agency when he told Baker in 2016 that he was not working “for any client” when he approached the FBI with his allegations. However, prosecutors allege that he was working for the Clinton campaign at the time, and that he billed the campaign for his work immediately after meeting Baker.
Sussman, who has pleaded not guilty, is being prosecuted by US Department of Justice Special Counsel John Durham, who was appointed by then Attorney General William Barr in 2019 to investigate the FBI’s handling of the ‘Russiagate’ investigation before Mueller took over.
Trump has insisted since 2016 that the allegations of “collusion” against him were a politically-motivated “witch hunt.”
Featured Video
Prof Seyed Marandi: Will the US Collapse the Global Economy?
or go to
Aletho News Archives – Video-Images
From the Archives
The toxic legacy of nuclear weapons testing serves as a stark warning of the danger these weapons pose
By Scott Ritter | RT | March 11, 2021
Millions of people suffer and die from the effects of radiation exposure from decades of nuclear weapons testing. Their experience should give serious pause to those who continue to embrace the viability of a nuclear deterrent. … continue
Blog Roll
Aletho News- Trump’s war on Iran becomes ‘most unpopular conflict’ in US history
- The Middle East is wringing its hands of Washington. Finally
- The Starmer legacy the establishment media won’t tell you: Celebrity sex crimes, imprisoning Assange and torture terror
- 13-18 DAYS: The PRACTICAL DIESEL BUFFER… Does It Preclude Bombing Iran?
- Prof Seyed Marandi: WILL the US COLLAPSE the GLOBAL ECONOMY?
- Larry Sanger Said Wikipedia Punishes Dissent. Then It Banned Him.
- How Darializa Avila Chevalier Is Different From Other Elected Progressives
- Israel Declares 464 Dunams in Sinjil as “State Land”
- Strait of Hormuz as strategic red line: Why Iran must confront Oman’s corridor plan and Trump’s threats
- House to vote on proposal ending $3.3bln in military aid to ‘Israel’
- If Americans Knew
- Four Reasons the Netanyahu-Backed Plan to ‘End’ U.S. Military Aid to Israel Is a Scam
- Archbishop of Canterbury vows to help Palestinians achieve ‘freedom you deserve,’ calls for end to Israeli occupation
- The scars left behind by Israel’s white phosphorus in Lebanon
- Drones and decomposing babies: What’s in UN report on Israel’s genocide of Palestinian children
- Crimson Thread: The new Israeli separation wall that cuts through the ‘breadbasket of Palestine’
- Gaza ceasefire talks back to square one as Israel changes the rules – Daily Update
- The NDAA Proposed Merger of the U.S. and Israeli Military is Strategically Unwise and Inherently Unconstitutional
- Victories by Pro-Palestinian Democrats Show the Party’s Shift on Israel
- Massie moves to strike $3.3B in Israel military aid from the budget
- How Jeffrey Epstein’s Israeli Network Shaped Congo’s Deadly Mineral Trade
- No Tricks Zone
- 2025 Study: Cloud Effects Reduce Downwelling Longwave Radiation, Overriding The CO2 Impact
- 3 New Studies Find Increasing Trends In Solar Radiation Since The 1980s – Easily Explaining Warming
- THE TRANSCEIVER PARADOX: Why Organoid Intelligence (OI) Could Become Our Ultimate Alien Predator
- German Wind Turbines Face Regulatory Shutdown Due To Excessive Noise
- New Study: Chile’s Relative Sea Level Was 3.2 Meters Higher Than Today During The Mid-Holocene
- Beyond The Pitch: Why FIFA’s World Cup Is One Of Humanity’s Best Investments
- Climate Alarmists Now Using Natural Phenomena To Support Their Claims
- New Study: Significant CO2 Fluxes From Non-Volcanic Sources Are Largely Neglected In Carbon Budgets
- Women Climate Scientists Being Harassed, Insulted By Skeptics, Claims Berkeley Earth Researcher
- Germany’s Longterm Spring Climate Data Show “No Climate Trend”
Aletho News 